| Followers | 19 |
| Posts | 6566 |
| Boards Moderated | 1 |
| Alias Born | 05/23/2019 |
Monday, January 30, 2023 4:53:04 AM
WISE WQLF SAYS; There hasn’t been any mention of CW Labs a Division of CW Holding Company since they collaborated with the University of Buffalo. Since that time the shareholders of Charlottes Web were funding the company. During the time of funding, Joel Stanley set up a competing company, AJNA Bioscience. The two major individuals collaborating with CW Labs are now major business partners with AJNA Bioscience. The office is located in Littleton, Colorado but fail to mention where their labs are located. The CW Labs are or were located in Louisville Colorado. The major Question and Concern is what has happened to CW Labs? Who is Benefiting from AJNA Bioscience? Besides Joel Stanley. Could this be the reason that there has been such a major turnover at. Charlotte’s Web, especially the CFO? Below are the connections of two individuals who were involved with the CW Labs collaboration at the University of Buffalo and are now major partners in Joel Stanley’s newest adventure that is not so new when one notices how far back AJNA was formed as a Delaware Corporation. If DV is correct that AJNA is not a Division of CW Holding Company, then one can most likely conclude that AJNA was seeded by Charlottes Web shareholders. IMO Have Mercy WQLF Ahooooooo
WISE WQLF’s Due Diligence on CW Labs AJNA Bioscience
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171066111
Jeff Lombardo and Gene Morse AJNA Bioscience Partners
https://www.ajnabiosciences.com/about-us
Dr. Joong J Fang Said
UNIVERSITY AT BUFFALO AND CHARLOTTE’S WEB ANNOUNCE COLLABORATION
STAFF·NOVEMBER 23, 2020
“ This new scientific initiative builds on early projects that have been envisioned with Dr. Gene D. Morse, Director of the Center for Integrated Global Biomedical Sciences (CIGBS) at the University at Buffalo and State University of New York (SUNY) Distinguished Professor.”
https://www.mary-magazine.com/lifestyle-culture/university-at-buffalo-and-charlottes-web-announce-collaboration/
University at Buffalo and Charlotte's Web Announce Collaboration to Advance Hemp Cannabinoid Science
Charlotte's Web R&D collaboration with University at Buffalo for the science on hemp CBD and other cannabinoids (CNW Group/Charlotte''s Web Holdings, Inc.)
NEWS PROVIDED BY
Charlotte''s Web Holdings, Inc.
Nov 19, 2020
“ This new scientific initiative builds on early projects that have been envisioned with Dr. Gene D. Morse, Director of the Center for Integrated Global Biomedical Sciences (CIGBS) at the University at Buffalo and State University of New York (SUNY) Distinguished Professor.”
https://www.prnewswire.com/news-releases/university-at-buffalo-and-charlottes-web-announce-collaboration-to-advance-hemp-cannabinoid-science-301176513.html
CIGBS partners with CW Labs to advance cannabinoid science
“ The initiative builds on the research of Gene Morse, SUNY Distinguished Professor in the UB School of Pharmacy and Pharmaceutical Sciences and CIGBS director.
The CIGBS is an international hub that addresses global health challenges through pharmacological research, education and training, and drug and vaccine development.”
https://www.buffalo.edu/news/releases/2020/11/037.html
Charlotte’s Web Supports Landmark Liver Safety Study
Published: Aug 28, 2021
“ A local researcher is working with CBD industry pioneer and market leader, Charlotte’s Web, to generate new data that helps answer this question. Dr. Jeff Lombardo, an assistant professor at the University of Buffalo’s Center for Integrated Global Biomedical Sciences is leading a collaborative research study into CBD’s effects on the liver. Charlotte’s Web, whose development lab is located in Buffalo, is one of twelve companies participating in the study. The initial cohort recently completed the first portion of the study and investigators, including Lombardo, met with the FDA to discuss the results.
https://cannabuff.com/articles/charlottes-web-supports-landmark-liver-safety-study
WISE WQLF’s Due Diligence on CW Labs AJNA Bioscience
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171066111
Jeff Lombardo and Gene Morse AJNA Bioscience Partners
https://www.ajnabiosciences.com/about-us
Dr. Joong J Fang Said
UNIVERSITY AT BUFFALO AND CHARLOTTE’S WEB ANNOUNCE COLLABORATION
STAFF·NOVEMBER 23, 2020
“ This new scientific initiative builds on early projects that have been envisioned with Dr. Gene D. Morse, Director of the Center for Integrated Global Biomedical Sciences (CIGBS) at the University at Buffalo and State University of New York (SUNY) Distinguished Professor.”
https://www.mary-magazine.com/lifestyle-culture/university-at-buffalo-and-charlottes-web-announce-collaboration/
University at Buffalo and Charlotte's Web Announce Collaboration to Advance Hemp Cannabinoid Science
Charlotte's Web R&D collaboration with University at Buffalo for the science on hemp CBD and other cannabinoids (CNW Group/Charlotte''s Web Holdings, Inc.)
NEWS PROVIDED BY
Charlotte''s Web Holdings, Inc.
Nov 19, 2020
“ This new scientific initiative builds on early projects that have been envisioned with Dr. Gene D. Morse, Director of the Center for Integrated Global Biomedical Sciences (CIGBS) at the University at Buffalo and State University of New York (SUNY) Distinguished Professor.”
https://www.prnewswire.com/news-releases/university-at-buffalo-and-charlottes-web-announce-collaboration-to-advance-hemp-cannabinoid-science-301176513.html
CIGBS partners with CW Labs to advance cannabinoid science
“ The initiative builds on the research of Gene Morse, SUNY Distinguished Professor in the UB School of Pharmacy and Pharmaceutical Sciences and CIGBS director.
The CIGBS is an international hub that addresses global health challenges through pharmacological research, education and training, and drug and vaccine development.”
https://www.buffalo.edu/news/releases/2020/11/037.html
Charlotte’s Web Supports Landmark Liver Safety Study
Published: Aug 28, 2021
“ A local researcher is working with CBD industry pioneer and market leader, Charlotte’s Web, to generate new data that helps answer this question. Dr. Jeff Lombardo, an assistant professor at the University of Buffalo’s Center for Integrated Global Biomedical Sciences is leading a collaborative research study into CBD’s effects on the liver. Charlotte’s Web, whose development lab is located in Buffalo, is one of twelve companies participating in the study. The initial cohort recently completed the first portion of the study and investigators, including Lombardo, met with the FDA to discuss the results.
https://cannabuff.com/articles/charlottes-web-supports-landmark-liver-safety-study
Bearish
Recent CWBHF News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/16/2026 07:03:53 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/16/2026 07:03:14 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/16/2026 07:02:48 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/14/2026 04:30:15 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/06/2026 09:07:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 06:32:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 06:31:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 06:29:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 11:18:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 09:30:13 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/01/2026 09:29:45 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 11:08:26 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 11:07:30 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/31/2026 11:07:11 AM
- Charlotte's Web Reports 2025 Fourth Quarter and Full Year Financial Results • PR Newswire (US) • 03/31/2026 11:07:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 10:46:21 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/31/2026 10:45:01 AM
- Charlotte's Web Announces Transaction with BAT: Debenture Conversion and US$10M Equity Investment to Strengthen Balance Sheet • PR Newswire (US) • 03/31/2026 02:59:00 AM
- Charlotte's Web 2025 Fourth Quarter and Year-End Earnings Call and Webcast Notice • PR Newswire (US) • 03/24/2026 01:15:00 PM
- Charlotte's Web Welcomes New CMS Guidance, Advancing Access to Eligible Full‑Spectrum Hemp Products • PR Newswire (US) • 03/21/2026 01:53:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 03:19:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 12:14:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:07:22 PM
